Orion Pharma (UK) Ltd

Information

Name

Type

Company

Roles

Supplier

Company Size

Sme

Company Number

Incorporation Date

Website

http://www.orionpharma.co.uk

Address

Reading

United Kingdom

Suppliers

Unlock the full supplier list, free!

Sign up to unlock the full list of suppliers associated with Orion Pharma (UK) Ltd
Sign up free

Contracts awarded to Orion Pharma (UK) Ltd

The contracts that Orion Pharma (UK) Ltd have been awarded to supply. Click on the contract to view more detailed information and view the full details about the contract won.

Award

Published 3 months ago

NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024

roject title: CM/PHS/24/5707 NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024 Period of framework: 1 August 2024 to 31 July 2025. with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months

£416,830,570 Bids close: 7 months ago
Award

Published 3 months ago

NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024

Project title: NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024 Offer reference number CM/PHS/24/5707 Period of framework: 1 August 2024 to 31 July 2025. with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months Published By: Medicines Procurement and Supply Chain – NHS Medicines Value & Access, NHS England The Procurement relates to the supply of medical retinal vascular Anti Veg-F and Intravitreal Corticosteroid medicines used in medical retinal vascular services for the NHS in England.

£9
Award

Published 6 months ago

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2)

Invitation to offer for NHS National Generic Pharmaceuticals - Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)

£424,035,364 Bids close: 1 year ago
Award

Published 7 months ago

NHS National Generic Pharmaceuticals Wave 14c

NHS National Generic Pharmaceuticals- Wave 14c Offer reference number: CM/PHG/22/5672 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 36 months with an option or options to extend (at the Authority’s discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Orals (plus non-parenteral) Products: All Regions (CESW/LSNE/NWLN):01/06/2024 to 31/05/2027 (36 Months) Hospital Only Products: DLS & DNE: 01/06/2024 to 31/05/2026(24 months) Hospital Only Products(Housekeeping): DLN & DNW: 01/06/2024 to 31/01/2025(8 months) DCE & DSW: 01/06/2024 to 30/09/2025(16 months)

£219

Orion Pharma (UK) Ltd

Information

Name

Type

Roles

Company Size

Company Number

Incorporation Date

Website

Address

Suppliers

Contracts awarded to Orion Pharma (UK) Ltd

NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024

NHS National Framework for Medical Retinal Vascular Treatments 1 August 2024

NHS National Generic Pharmaceuticals Wave 14c (CF Award - Part 2)

NHS National Generic Pharmaceuticals Wave 14c

Contacts

Statistics (1 Year)